5 Australian blood clot cases linked to AstraZeneca COVID-19 vaccine
CANBERRA, May 6 (Xinhua) -- Australia's medical regulator has linked five new cases of blood clotting to the AstraZeneca coronavirus vaccine.
John Skerritt, head of the Therapeutic Goods Administration, on Thursday announced that five recipients of the AstraZeneca vaccine have developed clotting and low platelets.
The patients included two men in their 70s, one in 60s, and two women in their 50s and 60s.